Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
Two new books, “The Sirens’ Call” by Hayes and “Superbloom” by Carr, argue that our capacity for attention and connection has been devastated by the digital age ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...